Literature DB >> 12433912

Pulmonary hypertension in the young.

Sheila G Haworth1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12433912      PMCID： PMC1767475          DOI： 10.1136/heart.88.6.658

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  17 in total

1.  The molecular composition of K(ATP) channels in human pulmonary artery smooth muscle cells and their modulation by growth.

Authors:  Yi Cui; Sandy Tran; Andrew Tinker; Lucie H Clapp
Journal:  Am J Respir Cell Mol Biol       Date:  2002-01       Impact factor: 6.914

2.  Pathobiology of pulmonary hypertension: Impact on clinical management.

Authors:  Marlene Rabinovitch
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2000

3.  Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction.

Authors:  E K Weir; H L Reeve; J M Huang; E Michelakis; D P Nelson; V Hampl; S L Archer
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

4.  Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

Authors:  D B Badesch; V F Tapson; M D McGoon; B H Brundage; L J Rubin; F M Wigley; S Rich; R J Barst; P S Barrett; K M Kral; M M Jöbsis; J E Loyd; S Murali; A Frost; R Girgis; R C Bourge; D D Ralph; C G Elliott; N S Hill; D Langleben; R J Schilz; V V McLaughlin; I M Robbins; B M Groves; S Shapiro; T A Medsger
Journal:  Ann Intern Med       Date:  2000-03-21       Impact factor: 25.391

5.  Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension.

Authors:  M W Geraci; B Gao; D C Shepherd; M D Moore; J Y Westcott; K A Fagan; L A Alger; R M Tuder; N F Voelkel
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

Review 6.  Hemodynamic forces are complex regulators of endothelial gene expression.

Authors:  N Resnick; M A Gimbrone
Journal:  FASEB J       Date:  1995-07       Impact factor: 5.191

7.  Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.

Authors:  K B Lane; R D Machado; M W Pauciulo; J R Thomson; J A Phillips; J E Loyd; W C Nichols; R C Trembath
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

8.  Onset and evolution of pulmonary vascular disease in young children: abnormal postnatal remodelling studied in lung biopsies.

Authors:  S M Hall; S G Haworth
Journal:  J Pathol       Date:  1992-02       Impact factor: 7.996

9.  Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension.

Authors:  S Eddahibi; M Humbert; E Fadel; B Raffestin; M Darmon; F Capron; G Simonneau; P Dartevelle; M Hamon; S Adnot
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

10.  Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.

Authors:  D W Johnson; J N Berg; M A Baldwin; C J Gallione; I Marondel; S J Yoon; T T Stenzel; M Speer; M A Pericak-Vance; A Diamond; A E Guttmacher; C E Jackson; L Attisano; R Kucherlapati; M E Porteous; D A Marchuk
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330
View more
  13 in total

1.  Interatrial shunt for chronic pulmonary hypertension: differential impact of low-flow vs. high-flow shunting.

Authors:  Andreas Zierer; Spencer J Melby; Rochus K Voeller; Marc R Moon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-09       Impact factor: 4.733

Review 2.  Pulmonary arterial hypertension: a comparison between children and adults.

Authors:  R J Barst; S I Ertel; M Beghetti; D D Ivy
Journal:  Eur Respir J       Date:  2011-03       Impact factor: 16.671

3.  Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension.

Authors:  Emilia Falcetti; Susan M Hall; Peter G Phillips; Jigisha Patel; Nicholas W Morrell; Sheila G Haworth; Lucie H Clapp
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

Review 4.  Surgical strategies for patients with congenital heart disease and severe pulmonary hypertension in low/middle-income countries.

Authors:  Sachin Talwar; Vikas Kumar Keshri; Shiv Kumar Choudhary; Saurabh Kumar Gupta; Sivasubramanian Ramakrishnan; Rajnish Juneja; Anita Saxena; Shyam Sunder Kothari; Balram Airan
Journal:  Heart Asia       Date:  2015-10-09

5.  Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension.

Authors:  A Micheletti; A A Hislop; A Lammers; P Bonhoeffer; G Derrick; P Rees; S G Haworth
Journal:  Heart       Date:  2005-11-08       Impact factor: 5.994

Review 6.  Factors relating caesarean section to persistent pulmonary hypertension of the newborn.

Authors:  Niralee Babooa; Wen-Jing Shi; Chao Chen
Journal:  World J Pediatr       Date:  2017-10-20       Impact factor: 2.764

7.  Impact of differential right-to-left shunting on systemic perfusion in pulmonary arterial hypertension.

Authors:  Timo Weimar; Yoshiyuki Watanabe; Toshinobu Kazui; Urvi S Lee; Alessandro Montecalvo; Richard B Schuessler; Marc R Moon
Journal:  Catheter Cardiovasc Interv       Date:  2012-11-14       Impact factor: 2.692

8.  Better Outcomes in Pulmonary Arterial Hypertension After Repair of Congenital Heart Disease, Compared With Idiopathic Pulmonary Arterial Hypertension.

Authors:  Zhuoyuan Xu; Michael A Gatzoulis; Konstantinos Dimopoulos; Qiangqiang Li; Chen Zhang; Bradley B Keller; Hong Gu
Journal:  CJC Open       Date:  2021-02-17

Review 9.  Pediatric pulmonary arterial hypertension.

Authors:  Dan-Chen Wu; Hong-Da Zhang; Zhi-Cheng Jing
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

10.  Prognostic Factors in Patients With Pulmonary Hypertension-A Nationwide Cohort Study.

Authors:  Wei-Ting Chang; Shih-Feng Weng; Chih-Hsin Hsu; Jhih-Yuan Shih; Jhi-Joung Wang; Chun-Ying Wu; Zhih-Cherng Chen
Journal:  J Am Heart Assoc       Date:  2016-08-29       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.